• Je něco špatně v tomto záznamu ?

Chemistry and Toxicology of Major Bioactive Substances in Inocybe Mushrooms

J. Patocka, R. Wu, E. Nepovimova, M. Valis, W. Wu, K. Kuca

. 2021 ; 22 (4) : . [pub] 20210223

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019202

Grantová podpora
VT2019-2021 UHK CEP - Centrální evidence projektů
2016YFD0501207, 2016YFD0501009 National Key R & D Program
31972741, 31572576 NSFC
2016T90477 China Postdoctoral Science Foundation
FN HK 00179906 Ministry of Health of the Czech Republic
PROGRES Q40 Charles University in Prague, Czech Republic

Mushroom poisoning has always been a threat to human health. There are a large number of reports about ingestion of poisonous mushrooms every year around the world. It attracts the attention of researchers, especially in the aspects of toxin composition, toxic mechanism and toxin application in poisonous mushroom. Inocybe is a large genus of mushrooms and contains toxic substances including muscarine, psilocybin, psilocin, aeruginascin, lectins and baeocystin. In order to prevent and remedy mushroom poisoning, it is significant to clarify the toxic effects and mechanisms of these bioactive substances. In this review article, we summarize the chemistry, most known toxic effects and mechanisms of major toxic substances in Inocybe mushrooms, especially muscarine, psilocybin and psilocin. Their available toxicity data (different species, different administration routes) published formerly are also summarized. In addition, the treatment and medical application of these toxic substances in Inocybe mushrooms are also discussed. We hope that this review will help understanding of the chemistry and toxicology of Inocybe mushrooms as well as the potential clinical application of its bioactive substances to benefit human beings.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019202
003      
CZ-PrNML
005      
20210830100753.0
007      
ta
008      
210728s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms22042218 $2 doi
035    __
$a (PubMed)33672330
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Patocka, Jiri $u Department of Radiology, Toxicology and Civil Protection, Faculty of Health and Social Studies, University of South Bohemia, 37005 Ceske Budejovice, Czech Republic $u Biomedical Research Centre, University Hospital, 50003 Hradec Kralove, Czech Republic
245    10
$a Chemistry and Toxicology of Major Bioactive Substances in Inocybe Mushrooms / $c J. Patocka, R. Wu, E. Nepovimova, M. Valis, W. Wu, K. Kuca
520    9_
$a Mushroom poisoning has always been a threat to human health. There are a large number of reports about ingestion of poisonous mushrooms every year around the world. It attracts the attention of researchers, especially in the aspects of toxin composition, toxic mechanism and toxin application in poisonous mushroom. Inocybe is a large genus of mushrooms and contains toxic substances including muscarine, psilocybin, psilocin, aeruginascin, lectins and baeocystin. In order to prevent and remedy mushroom poisoning, it is significant to clarify the toxic effects and mechanisms of these bioactive substances. In this review article, we summarize the chemistry, most known toxic effects and mechanisms of major toxic substances in Inocybe mushrooms, especially muscarine, psilocybin and psilocin. Their available toxicity data (different species, different administration routes) published formerly are also summarized. In addition, the treatment and medical application of these toxic substances in Inocybe mushrooms are also discussed. We hope that this review will help understanding of the chemistry and toxicology of Inocybe mushrooms as well as the potential clinical application of its bioactive substances to benefit human beings.
650    _2
$a Agaricales $x chemie $x metabolismus $x fyziologie $7 D000363
650    _2
$a zvířata $7 D000818
650    _2
$a lidé $7 D006801
650    _2
$a lektiny $x chemie $x farmakologie $7 D037102
650    _2
$a muskarin $x chemie $x otrava $x toxicita $7 D009116
650    _2
$a otrava houbami $x etiologie $x terapie $7 D009145
650    _2
$a organofosforové sloučeniny $x chemie $x toxicita $7 D009943
650    _2
$a psilocybin $x analogy a deriváty $x chemie $x otrava $x toxicita $7 D011562
650    _2
$a tryptaminy $x chemie $x toxicita $7 D014363
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Wu, Ran $u MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China
700    1_
$a Nepovimova, Eugenie $u Department of Chemistry, Faculty of Science, University of Hradec Králové, Rokitanského 62, 500 03 Hradec Kralove, Czech Republic
700    1_
$a Valis, Martin $u Department of Neurology of the Medical Faculty of Charles University and University Hospital in Hradec Kralove, Sokolska 581, 50005 Hradec Kralove, Czech Republic
700    1_
$a Wu, Wenda $u MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China $u Department of Chemistry, Faculty of Science, University of Hradec Králové, Rokitanského 62, 500 03 Hradec Kralove, Czech Republic
700    1_
$a Kuca, Kamil $u Biomedical Research Centre, University Hospital, 50003 Hradec Kralove, Czech Republic $u Department of Chemistry, Faculty of Science, University of Hradec Králové, Rokitanského 62, 500 03 Hradec Kralove, Czech Republic
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 22, č. 4 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33672330 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830100754 $b ABA008
999    __
$a ok $b bmc $g 1690105 $s 1139648
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 22 $c 4 $e 20210223 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a VT2019-2021 $p UHK
GRA    __
$a 2016YFD0501207, 2016YFD0501009 $p National Key R & D Program
GRA    __
$a 31972741, 31572576 $p NSFC
GRA    __
$a 2016T90477 $p China Postdoctoral Science Foundation
GRA    __
$a FN HK 00179906 $p Ministry of Health of the Czech Republic
GRA    __
$a PROGRES Q40 $p Charles University in Prague, Czech Republic
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...